 Pyxant 

Recent technological advancements have revolutionized our capacity to quantify cellular heterogeneity with spatial context, opening the doors to advanced studies with implications for drug development. This new and developing area, spatial biology goes beyond analyzing the drug’s impact on the targeted tissue, enabling the next generation of actionable clinical insights and could provide significant value to pharmaceutical companies.

Join this webinar to hear industry expert, Corinne Ramos, PhD., discuss exactly why Spatial Biology is not “hype”, but instead “hope” for drug development.



Shows the complex ecosystem in the tissue microenvironment

Shows biomarker conceptualization and location

Shows cell interactions and their response to disease progression or on treatment

Examines spatial analysis for precision medicine


Director of Research & Development
ImoBiotech

With more than 20 years of experience in leading innovative research and clinical programs, 

 has extensively worked on the identification and development of biomarkers to predict therapeutic outcomes. She is known for driving clinical development to successful commercialization. She holds a Ph.D in Molecular Biology from the University Paul Sabatier in Toulouse, France and a MBA from the Johns Hopkins University-Carey Business School in Washington DC, USA

Webcasts

Tuesday, November 15th, 2022 at 10 am EDT | 8 am CDT | 7 am PD
Spatial Biology is changing the drug development landscape. Validating efficacy with and actual image of the molecule interacting with the tissue provides the additional data needed to determine success or failure.  

Join the webinar on November 15th to learn more about the solutions Spatial Biology provides.  

Spatial Biology: Hype or Hope?


Importing and exporting biological samples to and from a US bioanalytical lab requires the US government’s oversight to prevent the transportation of exotic diseases and the supplying of illegal markets. Pharma companies and bioanalytical partners must proactively work together to secure the correct import or export licenses or permits prior to shipment to ensure international samples arrive intact and on time. In this webcast, learn more about how the process is navigated to help you successfully plan your study’s timeline and avoid compromising your samples in transit.



Learn what US government agencies are involved in licensing/permitting the import and export of biological samples

Determine which licenses/permits are required for which categories of biological materials

Understand license/permit application requirements and approval lead times

Mark Vann joined Pyxant Labs Colorado in 2018 and serves as the operations support manager, overseeing the inventory management of samples and compounds, international logistics, procurement, and special projects. Mark has worked with a variety of biotech and pharma companies to successfully import and export their biological samples.

Thu, Sep 29, 2022 11:00 AM EDT

Are your biological samples held up in customs? Understand how to import and export biological samples with efficiency in this webcast.
 

Pyxant

Articles